limb pain
Recently Published Documents


TOTAL DOCUMENTS

1312
(FIVE YEARS 298)

H-INDEX

64
(FIVE YEARS 8)

2022 ◽  
pp. 545-554
Author(s):  
Timothy Sowder ◽  
Usman Latif ◽  
Edward Braun ◽  
Dawood Sayed

2022 ◽  
pp. 127-138
Author(s):  
Derek M. Miletich ◽  
Lynita Mullins ◽  
C. Ryan Phillips

2022 ◽  
Vol 17 (1) ◽  
pp. 59
Author(s):  
Diana Cardona ◽  
MÁngeles Garcia-Pallero ◽  
Lola Rueda-Ruzafa ◽  
Miguel Rodriguez-Arrastia ◽  
Pablo Roman

PEDIATRICS ◽  
2021 ◽  
Author(s):  
Brian Vial ◽  
Margaret Lieb ◽  
Haley Pysick ◽  
Patrick Hettinger ◽  
Lynn Rusy ◽  
...  

Targeted muscle reinnervation (TMR) is a powerful new tool in preventing and treating residual limb and phantom limb pain. In the adult population, TMR is rapidly becoming standard of care; however, there is a paucity of literature regarding indications and outcomes of TMR in the pediatric population. We present 2 cases of pediatric patients who sustained amputations and the relevant challenges associated with TMR in their cases. One is a 7-year-old patient who developed severe phantom and residual limb pain after a posttraumatic above-knee amputation. He failed pharmacologic measures and underwent TMR. He obtained complete relief of his symptoms and is continuing to do well 1.5 years postoperatively. The other is a 2-year-old boy with bilateral wrist and below-knee amputations as sequelae of sepsis. TMR was not performed because the patient never demonstrated evidence of phantom limb pain or symptomatic neuroma formation. We use these 2 cases to explore the challenges particular to pediatric patients when considering treatment with TMR, including capacity to report pain, risks of anesthesia, and cortical plasticity. These issues will be critical in determining how TMR will be applied to pediatric patients.


2021 ◽  
Vol 7 (4) ◽  
pp. 1-7
Author(s):  
Kevin Pacheco-Barrios ◽  
Paulo Sampaio de Melo ◽  
Karen Vasquez-Avila ◽  
Alejandra Cardenas-Rojas ◽  
Paola Gonzalez-Mego ◽  
...  

Author(s):  
Francisco Manoel Branco Germiniani ◽  
Carlos Henrique Ferreira Camargo ◽  
Léo Coutinho ◽  
Hélio Afonso Ghizoni Teive

ABSTRACT Even though jazz is a musical style that excels in improvisation and virtuosity, it is not without its share of anecdotes, drama, and downright tragedy, and the biographies of jazz musicians and their demise are fraught with ominous and dire straits. Unsurprisingly, some would develop chronic and fatal diseases. The neurological diseases that afflicted the following six composers and musicians, all of whom are considered jazz legends, are briefly discussed: Charles Mingus, diagnosed with amyotrophic lateral sclerosis; Lester Young and Charlie Parker, both diagnosed with neurosyphilis; Thelonius Monk, who had possible frontotemporal dementia; George Gershwin, who died as a result of brain glioma; and Cole Porter, who developed phantom limb pain following an amputation. The association of lifestyles, with drug abuse, particularly alcohol and heroin, in addition to great sexual promiscuity factors contributed to the development of a series of diseases such as syphilis. In addition, we also described some fatalities such as neurodegenerative diseases and cerebral glioma.


PM&R ◽  
2021 ◽  
Author(s):  
Emma Haldane Beisheim‐Ryan ◽  
Gregory Evan Hicks ◽  
Ryan Todd Pohlig ◽  
Jared Medina ◽  
Jaclyn Megan Sions

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
André Tadeu Sugawara ◽  
Marcel Simis ◽  
Felipe Fregni ◽  
Linamara Rizzo Battistella

Introduction. There is no diagnosis for phantom limb pain (PLP), and its investigation is based on anamnesis, which is subject to several biases. Therefore, it is important to describe and standardize the diagnostic methodology for PLP. Objective. To characterise PLP and, secondarily, to determine predictors for its diagnosis. Methodology. This is a cross-sectional study involving patients with unilateral traumatic lower-limb amputation aged over 18 years. Those with clinical decompensation or evidence of disease, trauma, or surgery in the central or peripheral nervous system were excluded. Sociodemographic and rehabilitative data were collected; PLP was characterised using the visual analogue scale (VAS), pain descriptors, and weekly frequency. Results. A total of 55 eligible patients participated in the study; most were male, young, above-knee amputees in the preprosthetic phase of the rehabilitation. The median PLP VAS was 60 (50–79.3) mm characterised by 13 (6–20) different descriptors in the same patient, which coexist, alternate, and add up to a frequency of 3.94 (2.5–4.38) times per week. The most frequent descriptor was movement of the phantom limb (70.91%). Tingling, numbness, flushing, itchiness, spasm, tremor, and throbbing are statistically significant PLP descriptor numbers per patient predicted by above-knee amputation, prosthetic phase, higher education level, and greater PLP intensity by VAS ( p < 0.05 ). Conclusion. PLP is not a single symptom, but a set with different sensations and perceptions that need directed and guided anamnesis for proper diagnosis.


Sign in / Sign up

Export Citation Format

Share Document